Literature DB >> 25241802

Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times.

Shlomi Cohen1, Ella Vainer2, Michael A Matar2, Nitsan Kozlovsky2, Zeev Kaplan2, Joseph Zohar3, Aleksander A Mathé4, Hagit Cohen1.   

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis displays a characteristic circadian pattern of corticosterone release, with higher levels at the onset of the active phase and lower levels at the onset of the inactive phase. As corticosterone levels modify the response to stress and influence the susceptibility to and/or severity of stress-related sequelae, we examined the effects of an acute psychological trauma applied at different zeitgeber times (ZTs) on behavioral stress responses. Rats were exposed to stress either at the onset of the inactive-(light) phase (ZT=0) or at the onset of the active-(dark) phase (ZT=12). Their behavior in the elevated plus-maze and acoustic startle response paradigms were assessed 7 days post exposure for retrospective classification into behavioral response groups. Serum corticosterone levels and the dexamethasone suppression test were used to assess the stress response and feedback inhibition of the HPA axis. Immunoreactivity for neuropeptide Y (NPY) and NPY-Y1 receptor (Y1R) in the paraventricular (PVN) and arcuate (ARC) hypothalamic nuclei, hippocampus, and basolateral amygdala were measured. The behavioral effects of NPY/Y1R antagonist microinfused into the PVN 30 min before stress exposure during the inactive or active phase, respectively, were evaluated. PVN immunoreactivity for NPY and Y1R was measured 1 day after the behavioral tests. The time of day of the traumatic exposure markedly affected the pattern of the behavioral stress response and the prevalence of rats showing an extreme behavioral response. Rats exposed to the stressor at the onset of their inactive phase displayed a more traumatic behavioral response, faster post-exposure corticosterone decay, and a more pronounced stress-induced decline in NPY and Y1R expression in the PVN and arcuate hypothalamic nuclei. Blocking PVN Y1R before stress applied in the active phase, or administering NPY to the PVN before stress applied in the inactive phase, had a resounding behavioral effect. The time at which stress occurred significantly affected the behavioral stress response. Diurnal variations in HPA and NPY/Y1R significantly affect the behavioral response, conferring more resilience at the onset of the active phase and more vulnerability at the onset of the inactive phase, implying that NPY has a significant role in conferring resilience to stress-related psychopathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25241802      PMCID: PMC4289967          DOI: 10.1038/npp.2014.257

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  66 in total

1.  Animal models of post-traumatic stress disorder.

Authors:  Hagit Cohen; Michael A Matar; Zohar Joseph
Journal:  Curr Protoc Neurosci       Date:  2013-07

Review 2.  Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event.

Authors:  R Yehuda; A C McFarlane; A Y Shalev
Journal:  Biol Psychiatry       Date:  1998-12-15       Impact factor: 13.382

3.  Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.

Authors:  H A Wieland; W Engel; W Eberlein; K Rudolf; H N Doods
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

4.  A two focal plane method for digital quantification of nuclear immunoreactivity in large brain areas using NIH-image software.

Authors:  H E Brown; M M Garcia; R E Harlan
Journal:  Brain Res Brain Res Protoc       Date:  1998-06

5.  Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress.

Authors:  R J Windle; S A Wood; N Shanks; S L Lightman; C D Ingram
Journal:  Endocrinology       Date:  1998-02       Impact factor: 4.736

6.  Neuropeptides and electroconvulsive treatment.

Authors:  A A Mathé
Journal:  J ECT       Date:  1999-03       Impact factor: 3.635

Review 7.  An animal model of posttraumatic stress disorder: the use of cut-off behavioral criteria.

Authors:  Hagit Cohen; Joseph Zohar
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

8.  The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.

Authors:  Hagit Cohen; Tianmin Liu; Nitsan Kozlovsky; Zeev Kaplan; Joseph Zohar; Aleksander A Mathé
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

9.  Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.

Authors:  L I Serova; A Tillinger; L G Alaluf; M Laukova; K Keegan; E L Sabban
Journal:  Neuroscience       Date:  2013-01-30       Impact factor: 3.590

10.  Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus.

Authors:  P E Sawchenko; L W Swanson; R Grzanna; P R Howe; S R Bloom; J M Polak
Journal:  J Comp Neurol       Date:  1985-11-08       Impact factor: 3.215

View more
  19 in total

1.  Albeit nocturnal, rats subjected to traumatic brain injury do not differ in neurobehavioral performance whether tested during the day or night.

Authors:  Peter J Niesman; Jiahui Wei; Megan J LaPorte; Lauren J Carlson; Kileigh L Nassau; Gina C Bao; Jeffrey P Cheng; Patricia de la Tremblaye; Naima Lajud; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Lett       Date:  2017-12-08       Impact factor: 3.046

2.  Stress-induced neuroinflammatory priming is time of day dependent.

Authors:  Laura K Fonken; Michael D Weber; Rachel A Daut; Meagan M Kitt; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Psychoneuroendocrinology       Date:  2016-01-11       Impact factor: 4.905

Review 3.  Stress and aging act through common mechanisms to elicit neuroinflammatory priming.

Authors:  Laura K Fonken; Matthew G Frank; Andrew D Gaudet; Steven F Maier
Journal:  Brain Behav Immun       Date:  2018-07-17       Impact factor: 7.217

4.  The behavioral and neurochemical effects of an inescapable stressor are time of day dependent.

Authors:  Rachel A Daut; J Russell Ravenel; Linda R Watkins; Steven F Maier; Laura K Fonken
Journal:  Stress       Date:  2020-01-20       Impact factor: 3.493

5.  Influencing circadian and sleep-wake regulation for prevention and intervention in mood and anxiety disorders: what makes a good homeostat?

Authors:  Ellen Frank; Marion Benabou; Brandon Bentzley; Matt Bianchi; Tina Goldstein; Genevieve Konopka; Elizabeth Maywood; David Pritchett; Bryony Sheaves; Jessica Thomas
Journal:  Ann N Y Acad Sci       Date:  2014-12       Impact factor: 5.691

6.  The Role of Neuropeptide Y mRNA Expression Level in Distinguishing Different Types of Depression.

Authors:  Yingying Yue; Haitang Jiang; Yingying Yin; Yuqun Zhang; Jinfeng Liang; Shenghua Li; Jun Wang; Jianxin Lu; Deqin Geng; Aiqin Wu; Yonggui Yuan
Journal:  Front Aging Neurosci       Date:  2016-12-27       Impact factor: 5.750

Review 7.  Diet-Induced Obesity and Circadian Disruption of Feeding Behavior.

Authors:  Aurea Blancas-Velazquez; Jorge Mendoza; Alexandra N Garcia; Susanne E la Fleur
Journal:  Front Neurosci       Date:  2017-02-07       Impact factor: 4.677

8.  A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder.

Authors:  Sehrish Sayed; Nicholas T Van Dam; Sarah R Horn; Marin M Kautz; Michael Parides; Sara Costi; Katherine A Collins; Brian Iacoviello; Dan V Iosifescu; Aleksander A Mathé; Steven M Southwick; Adriana Feder; Dennis S Charney; James W Murrough
Journal:  Int J Neuropsychopharmacol       Date:  2018-01-01       Impact factor: 5.176

Review 9.  Neuropeptide Y: A stressful review.

Authors:  Florian Reichmann; Peter Holzer
Journal:  Neuropeptides       Date:  2015-09-30       Impact factor: 3.286

10.  Is PTSD-Phenotype Associated with HPA-Axis Sensitivity?: The Endocannabinoid System in Modulating Stress Response in Rats.

Authors:  Dor Danan; Doron Todder; Joseph Zohar; Hagit Cohen
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.